Relief Therapeutics Holding Stock Analysis
| RLFTY Stock | USD 5.00 0.68 15.74% |
Relief Therapeutics Holding is overvalued with Real Value of 4.26 and Hype Value of 5.0. The main objective of Relief Therapeutics otc analysis is to determine its intrinsic value, which is an estimate of what Relief Therapeutics Holding is worth, separate from its market price. There are two main types of Relief Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Relief Therapeutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Relief |
Relief OTC Stock Analysis Notes
The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Relief Therapeutics recorded a loss per share of 1.5. The entity had not issued any dividends in recent years. The firm had 3:4 split on the 3rd of November 2022. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. Relief Therapeutics is traded on OTC Exchange in the United States.The quote for Relief Therapeutics Holding is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Relief Therapeutics Holding contact the company at 41 44 723 59 59 or learn more at https://www.relieftherapeutics.com.Relief Therapeutics Investment Alerts
| Relief Therapeutics is way too risky over 90 days horizon | |
| Relief Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 3.32 M. Net Loss for the year was (34.7 M) with profit before overhead, payroll, taxes, and interest of 2.57 M. | |
| Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07. |
Relief Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 128.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Relief Therapeutics's market, we take the total number of its shares issued and multiply it by Relief Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 18th of December 2024, Relief Therapeutics holds the Coefficient Of Variation of 716.01, risk adjusted performance of 0.1105, and Semi Deviation of 6.27. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Relief Therapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Relief Therapeutics, which can be compared to its competitors.Relief Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Relief Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Relief Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Relief Therapeutics Predictive Daily Indicators
Relief Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Relief Therapeutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Relief Therapeutics Forecast Models
Relief Therapeutics' time-series forecasting models are one of many Relief Therapeutics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Relief Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Relief OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Relief Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Relief shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Relief Therapeutics. By using and applying Relief OTC Stock analysis, traders can create a robust methodology for identifying Relief entry and exit points for their positions.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. Relief Therapeutics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Relief Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Additional Tools for Relief OTC Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.